Table 2 Summary of the views of the participants on alternative approaches to these therapeutic options for a man with circulatory failure in the context of a community-acquired pneumonia
Would you manage this patient with ... | Dr AW | Dr NW | Dr TT | Dr CL | Dr AL | Dr ML | Dr NH | Dr SN | Dr SH | Dr HC |
|---|---|---|---|---|---|---|---|---|---|---|
Early empiric antibiotics (ceftriaxone and azithromycin) | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
Early volume resuscitation | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
Colloid | Yes, in combination with crystalloid | No | No | No | Yes, in combination with crystalloid | No | No | Yes, in combination with crystalloid | Yes, in combination with crystalloid | No |
Crystalloid | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Lactated Ringers | Agree |
Packed red blood cells | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | No |
Dobutamine | Agree | Agree | Agree | No | Agree | Agree | Agree | Agree | Agree | No |
Empiric steroids | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
Cosyntropin test | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
DC steroids if cortisol change >9 | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
Line for CVP monitoring | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
PA Catheter | If persistent hypotension and oliguria with CVP >12 cmH2O | If persistent hypotension and oliguria with CVP >12 cmH2O | If persistent hypotension and oliguria with CVP >12 cmH2O | If persistent hypotension and oliguria with CVP >12 cmH2O | No | If persistent hypotension and oliguria with CVP >12 cmH2O | If persistent hypotension and oliguria with CVP >12 cmH2O | Agree | No | No |
Drotrecogin alpha (activated) | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |